Answers are grounded in this paper and cite their sources.
The short-term efficacy and safety of daridorexant, a dual orexin receptor antagonist, has been demonstrated in Japanese patients with insomnia disorder. The objective of this study was to evaluate, in a non-overlapping patient population to the short-term study, the long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder.
No takes yet. Share an insight, caveat, or question.
Uchimura et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: